Northwest Biotherapeutics Inc (QB) (NWBO) Share Price

Moreover, LP made it a point to say how refreshingly cooperative the MHRA was to approve the PIP in nearly half the standard time. That's a pretty strong signal or a read between the lines kind of statement IMHO.

“Throw back the little ones and pan fry the big ones. Use tact, poise and reason. And gently squeeze them”

One thing I think many forget is that MHRA can designate a new drug as a “ Promising Innovative Medicine”. DCVAX-L was the first drug out of all of biopharma to be awarded the (PIM) designation.

Up the food chain bozo.

biosectinvestor,

I am just using NWBO language and having had discussions with someone very knowledgeable about product security issues, the possibility does seem to be in the realm of possibilities. So I accept that this is not your likely choice or preference but also not discounted by NWBO but rather pointed to by language, which in NWBO land always seems to be up for interpretation; ). Thanks for all you do here. Best wishes.

exwannabe,

Not everyone in these big organizations needs to be involved. FINRA didn’t do too well with Bernie Madoff either when stuff first came up. As I recall it took a deeper look later on. Best wishes.

Ok Bro, but you have told everybody about 100 times. We have all heard your warning to save all us shareholders. You have done a splendid job. Now you can move on and save thousands of people in other stocks

Nemesis,

You mean like when I pointed out to you that patients who received a second resection then crossed over to DCVax-L did significantly worse than those who did not have a second resection before crossing over to L?; ). Patient lives matter to you don’t they? How about Kat’s cure and Mr. Powers doing so well so long. Every negative post is a reminder that you are ignoring and discounting the value of the lives of those who are alive today because L worked well for them. I will continue to remind you and others of this on a regular basis while you insist by your actions that poker table rules fully apply here; ). Best wishes.

I think that you've just highlighted how mentally trapped you are in this forum's Hive Mind, that when I'm literally telling you the truth right to your face, you don't or won't believe it !

Well, it's almost August. I like to be accurate with my estimates, but I've learned not to expect too much and to avoid being overly optimistic—unlike those folks who said it would be approved in March, April, May, June, or July. I think it will be around October, but it could be 2025. Who knows? There might even be a refusal for some minor adjustment, which would, of course, be another blow to the share price and could mean another year to file and get a new decision. Who knows what's going to happen? All I know is that if the MHRA were really enthusiastic about the vaccine, they would prioritize it. However, I don’t see it that way, especially considering how long it took just to provide the receipt or acceptance letter. To me, it looks like they are treating DCVax as part of the normal approval process. I hope I'm wrong.

Cvm offering. When's nwbo offering?

iclight,

Again, make your unsubstantiated claim now about how Advent is just for Linda but when approval comes and shareholders benefit from initial ramp up then max trajectory with Flaskworks feel free to say you were wrong or hasta la vista bebe; ). Best wishes.

Definitely, gaslighting volume 2 days are the same. How they get away with this is amazing.

You are a Joke. “Protect both the NHS and future cancer patients from an egregious fraud” What a crock of KRAP

In investment terms, your disbelief will be your financial downfall, I'm afraid. -3.8%

Sure you are

As a point of order, I will make it quite clear that all I state here is not misinformation, nor am I incentivised in anyway to post my views.

I am solely here to protect both the NHS and future cancer patients from an egregious fraud, whether that be from the DCVAX-L or Dcvax-DIRECT. Enterprises.

No guilt assigned to the skeptics. Legacy shareholders are down 99.X% under this management which means they'll never see a return. You can pretend it's not true but that's on you.


>>they're just as guilty

It's important to remember the names of the shills and pumpers who willingly and incessantly tried to get more investors to buy into this company. For all the crying they do about "fudsters, shorts, forces" etc... they're just as guilty of dragging other people down with them with their baseless pumping.

I hope the lawsuit goes to discovery just so both parties can expose the idiots on Twitter and ihub who've spread misinformation regarding the companies success.

You have zero insights.

Once again, I can tell by your reply that you are blinded by your own invested interest, no more.

LOL. Unless they have a friendly at MHRA willing to provide some limited support. No beef in it for shareholders but Advent might get the bone.

Im at point now that I just got to stop looking at the stock everyday. NWBO has never done anything ahead of schedule or on schedule. Its just the way it is. Disappointed in stock today.

Wrong as usual.

It’s over 100% profit since all you guys lie about buying at .17. Not the cheapies at 2,3,4,10 dollars. Is it 2 billion OS yet?

Is this related to DCVax-L?

Yeah she’s trailblazing trying to get approval in irrelevant UK because she already knows the redone trial has zero chance for FDA approval. She knows there’s zero chance for MHRA approval too but it gave her over a year to kick the can down the road to finance Advent. Then she’ll reboot zero ORR Direct to buy more time. She knew the rejection would take over a year while you guys were saying approval in 120 days.

I've polluted my this board by highlighting and posting probably one hundred current GBM articles here, and barely a reply.

2025? Seriously?
Do you think Merck has the patience to wait until 2025? Both Merck and Amgen finished their biologic manufacturing facility at light speed. Now you want them to wait until 2025. Have some common sense.

Stupp is more well respected AND the company paid him and he still can’t say anything good about the crappy trial’s data.

And the replying longs feed those beast every single day. I have them both on ignore and do not suffer fools, but many here do. How ignorant is that?

dennisdave,

Read up. “Remarks To The Alliance For Regenerative Medicine’s Annual Board Meeting”
May 22, 2018

Concerning challenges to cell and gene therapy..

Quote: “.. there’s another potentially greater challenge that currently appears to be slowing the advance of gene therapy. That challenge is the current limitation in manufacturing capabilities for both cellular and gene therapies.

Speaking about goals at FDA

Quote: Accelerate availability of emerging therapies by enabling the rapid scale-up of processes for manufacturing and standards development, including cell and gene therapies…”

Quote: We’re now working with sponsors, particularly those working with small populations, to consider developing scalable manufacturing processes with inherent quality attributes that can potentially support scale up and licensure. One way this might be accomplished technically is through the use of manufacturing “cassettes” that produce sufficient product for a limited number of individuals, say ten or twenty, which might be sufficient to supply an initial clinical trial.

NWBO has been in ongoing talks with FDA and cassettes are what Flaskworks worked to develop. This 2018 presentation by FDA is obviously some of what was discussed. Care to imagine how NWBO chose to lead them to or respond to these comments or do you just want to insist that realistic scalability for cell therapies is not important to FDA?; ). Best wishes.

Nemesis and LearningCurve have been polluting the board all day. LC pollutes the board everyday of the year. Great Life that person must have to post on a Message Board 24/7

Looks like SEC is aligned with the evil doers here.

They had a rep at the last Wolfpack meeting. You musta missed him.

Well get lost

Kennny is constantly pitting internal teams against internal teams for performance. Losers get booted off the Citadel. My guess is some of those guys at least know how much whistle blowers can be reimbursed.

"At this point, chances are it could be 2025,"

You are of course referring to the MAA approval but you have not
told us what bread crumbs have led you to believe that the decision
to approve or reject the MAA may be forthcoming more than a year
after its submission on 12/20/23. The most recent estimate for the
average time it takes for the MHRA to approve an MAA was 333
days and you are saying that our 150 day fast track MAA may take
more than 375 days. Kindly explain your reason for this estimate.

Also found in the data from the poly-iclc trial on the target adopted in Abbvie ADC which is MET. I also added several rows of normal genes.
Mutated gene MET can be overexpressed on GBM and fixed by DCVax-L.

Has anyone wondered why BPs are hiring people on computational biology like crazy? What would happen if data like these from hundreds of patients with different types cancer are pooled together? Can AI or machine-learning pinpoint what types of cancers share highly overexpressed mutated genes?

People lie. But data don't lie.

AbbVie ADC tops oncologist ranking of most exciting cancer candidates
https://www.fiercepharma.com/marketing/abbvie-adc-tops-oncologist-ranking-most-exciting-cancer-candidates

You’re a scammer. You have no basis to make any claims here and your accusations are both empty and non-scientific. You’re not on anyone’s side but your own as both a stalker and psycho. Quit stalking. If you had a case you’d not be posting on an investor board here. Your tactics and purpose are clear as day and it had nothing to do with patients or helping anyone. You’re just as likely to be stalking people at NHS, the MHRA and NICE as you are us here and people at King’s College. You’re out of control.

I think their gaslighting is running on fumes only. When the lights are fully turned on, their gaslighting will be relegated again back into the dark corners.

Dow up big, nwbo sucking as usual, as predicted when I sold 60k shares yesterday. I will get .35 or lower (probably .30) on the buy back in, but at least my sale money is making money. 3 or more months to approval leaves a lot of dropping room for this stock, and silent management cares not a peep. Funny how that works as they got paid and we did not. No matter what happens, LP got rich, and that's the way she planned it.

You clearly do not. And you didn’t have it. You are what you accuse others of, unfortunately. Get some mental help. Seriously. Stalking doctors, patients, their loved ones and investors invested here is ugly.

https://www.wsj.com/finance/stocks/u-s-accuses-prominent-short-seller-andrew-left-of-fraud-0161e42f

Poor EX is in denial

Like the captain in TITANIC..

He will go down with his BASHER ship n crew

full of bashers now; lets see how we close.

Take advantage of an endless pit? The only way this could improve is with approval, but we don't know when that might happen. At this point, chances are it could be 2025, and there’s NOTHING to boost the share price in the meantime. What are the chances that .20 is the bottom when the result may come up next year.

Just half. LOL

https://br.pinterest.com/pin/ben-rickert--324048135698886096/

That's all they do is miss the point. LOL.

NWBO could not have picked a worse Regulatory Authority with which to negotiate a premium Priced Product with.

If it meant reducing the price, they'd ask you to remove the skin of a fart, as they will only pay for the pure gas! 💨

So unless Advent can start spitting out 'vaccines' in an approved automated process, to reduce the price point, it's a losing battle before you start.

That's more than my total ;) just a small fry here.